Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,458 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06162234Recruiting
High Myopia Study in Wuhan
This study looks at how high myopia (severe nearsightedness) affects the eye over time. It aims to better understand the condition and improve care for people with high myopia.
Wuhan, HubeiAges 18–65 - NCT05139524Recruiting
Fever and bleeding illness study in East and Central Africa
This study looks at people with fever or unexplained bleeding in East and Central Africa to learn more about illnesses like Rift Valley fever. By joining, you can help doctors understand and better treat these conditions.
Goma, North KivuAges 2 years+ - NCT07854327Recruiting
Lymphatic drainage treatment for Alzheimer's disease
This trial tests a procedure to improve the brain's waste-clearing system, which may slow the effects of Alzheimer's disease. It's a new approach that aims to help the brain work better.
Siena, TuscanyAges Any age - NCT07872995Recruiting
Rural fitness tracker study for vitality and endurance
This study tests a program designed to help people in rural areas improve their physical activity and overall health using fitness trackers and other tools. It may help you understand your health better and become more active.
Great Falls, MontanaAges 18 years+ - NCT05604560RecruitingPhase 2
New drug combo before surgery for resectable pancreatic cancer
This trial tests two drugs, tislelizumab and SX-682, given before surgery for people with pancreatic cancer that can be removed. The goal is to see if this combination shrinks tumors and improves outcomes.
Baltimore, MarylandAges 18 years+ - NCT07793630RecruitingPhase 4
Laser and foam treatment for spider and reticular leg veins
This study compares two treatments for small, visible leg veins (spider veins and slightly larger blue or green veins). It tests whether using a laser along with foam sclerotherapy (a medicine injected into the veins) works better than foam alone.
Ribeirão Preto, São PauloAges 18–60 - NCT07856212Recruiting
Maintenance treatment for advanced stomach cancer in Colombia
This study looks at people with advanced stomach cancer who received a maintenance treatment after initial therapy. The goal is to see how well this approach works in real-world patients in Colombia.
Bogotá, Bogota D.C.Ages 18 years+ - NCT07854210Recruiting
High-flow nasal oxygen versus non-invasive ventilation for COPD
This trial compares two breathing support methods for people hospitalized with COPD and mild-to-moderate carbon dioxide retention. It aims to see if high-flow nasal oxygen is as effective as the standard mask-based ventilation.
Al Mansurah, Dakahlia GovernorateAges 40 years+ - NCT07862010RecruitingEarly Phase 1
Study of GI001 for B-cell lymphoma and leukemia that has returned or not responded
This trial tests a new treatment called GI001 for people with B-cell lymphoma or B-cell leukemia that has come back or hasn't responded to previous treatments. It aims to see if GI001 can help when other options have failed, and it may be an option if you haven't had CAR-T therapy before.
Yunnan, KunmingAges 18–75 - NCT05896592Recruiting
Ablation versus changing pacing settings for slow heartbeats
This study compares a procedure called cardioneuroablation with staying on permanent pacing in people who have symptoms from a slow heart rate. It aims to see which approach works better and is safer for reducing symptoms related to sinus node or heart conduction problems.
Radom, Masovian VoivodeshipAges 18–65 - NCT06197139RecruitingPhase 1
Study of a new targeted radiation therapy for advanced solid tumors
This trial tests an investigational drug called [177Lu]Lu-XT117, which delivers a small dose of radiation directly to cancer cells that have a specific protein called FAP. It is for people with advanced solid tumors who have run out of standard treatment options or cannot tolerate them.
GuangzhouAges 18 years+ - NCT03371407Recruiting
Study brain movement training in people with Parkinson’s
This study looks at how people with Parkinson’s adapt their movements and how their brain sensorimotor system works. It may help researchers improve understanding of Parkinson’s and refine movement-focused therapies.
MarseilleAges 18 years+ - NCT06189820RecruitingPhase 2
FAP protein as a marker for fibrotic lung disease
This trial is looking at a protein called FAP in the blood of people with fibrotic lung diseases. It aims to understand how this protein might be used as a marker to help doctors better diagnose and track these conditions.
BrusselsAges 18 years+ - NCT06190639RecruitingPhase 2
Sintilimab after surgery for node-positive esophageal cancer
This trial tests whether giving the immunotherapy drug Sintilimab after surgery can help prevent esophageal cancer from coming back. It is for people whose cancer had spread to lymph nodes and who have already had their tumor removed.
Hangzhou, ZhejiangAges 18 years+ - NCT06189950Recruiting
Testing a new stent for wide-necked brain aneurysms
This trial is testing a new stent (a small mesh tube) designed to treat wide-necked brain aneurysms. If you have this type of aneurysm, the stent helps hold coils in place to block blood flow and prevent rupture.
Zhengzhou, HenanAges 18–80 - NCT06192251Recruiting
Lifestyle medicine program for chronic conditions
This trial tests a complete lifestyle medicine program to help people with conditions like prediabetes, diabetes, high blood pressure, heart disease, high cholesterol, or being overweight. The program aims to improve your overall health through diet, exercise, and other lifestyle changes.
Parry Sound, OntarioAges 18 years+ - NCT04884620Recruiting
Copenhagen puberty study for healthy Caucasian youth
This study looks at how puberty changes happen in healthy children and teens. By tracking normal development, researchers hope to better understand puberty timing and patterns.
CopenhagenAges 5–19 - NCT06194968Recruiting
Stroke treatment with urokinase in real-world settings
This study looks at how well the clot-busting drug urokinase works for treating acute ischemic stroke in everyday medical practice. It may help if you have had a stroke and are eligible for clot-dissolving medication.
Lanzhou, GansuAges 18 years+ - NCT06197048Recruiting
Nutrition counseling for schizophrenia or bipolar disorder
This study tests whether nutritional counseling can improve body measurements and health markers in people with schizophrenia, psychosis, or bipolar disorder. It may help you manage weight and overall health.
Drammen, AkershusAges 18 years+ - NCT06199427RecruitingPhase 2
Preventing graft-versus-host disease after stem cell transplant for immune disorders
This trial tests a combination of two drugs, ruxolitinib and PTCy, to prevent graft-versus-host disease (a common complication) in children receiving a stem cell transplant for inborn errors of immunity. The goal is to make the transplant safer and more effective.
MoscowAges birth–21 years - NCT05603520Recruiting
Study of how the aorta varies in healthy people and patients
This study uses MRI scans to understand how different parts of the aorta look and behave, including in healthy volunteers and people with aortic problems. It may help researchers better describe differences in the aorta that could improve future diagnosis or treatment planning.
DüsseldorfAges 18 years+ - NCT06194669Recruiting
VHL disease and kidney tumor risk study
This study looks at how early changes in kidney cells can lead to tumors in people with VHL disease. It may help understand why some people develop kidney cancer and how to prevent it.
MilanAges 18 years+ - NCT06162559RecruitingPhase 1
Targeted therapy before surgery for HER2+ breast cancer
This trial tests a combination of three targeted drugs (trastuzumab, pertuzumab, and tucatinib) without chemotherapy before surgery for HER2-positive breast cancer. It aims to see if this approach can shrink tumors effectively while avoiding chemotherapy side effects.
AmsterdamAges 18 years+ - NCT07864207RecruitingPhase 1/Phase 2
Study of IDP-121 for small cell lung cancer that stopped responding to platinum
This trial tests a new drug, IDP-121, alone or with another chemo drug, for people with small cell lung cancer that came back after initial treatment. The goal is to see if it can shrink tumors and help people live longer.
BarcelonaAges 18 years+
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,458 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.